{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:55:21Z","timestamp":1791568521658,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinthera.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T18:00:33Z","timestamp":1698775233000},"page":"74-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Muscle Strength Decline Caused by Eperisone Hydrochloride: A Case Report"],"prefix":"10.1016","volume":"46","author":[{"given":"Junteng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiecheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-6327","authenticated-orcid":false,"given":"Chengfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.10.003_bib0001","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.pharep.2016.05.003","article-title":"Clinical efficacy and safety of eperisone for low back pain: a systematic literature review","volume":"68","author":"Bavage","year":"2016","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.clinthera.2023.10.003_bib0002","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/0022-3859.90076","article-title":"Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Chandanwale","year":"2011","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.clinthera.2023.10.003_bib0003","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejp.907","article-title":"Efficacy and tolerability of muscle relaxants for low back pain: systematic review and meta-analysis","volume":"21","author":"Abdel Shaheed","year":"2017","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clinthera.2023.10.003_bib0004","first-page":"459","article-title":"Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans","volume":"7","author":"Iwase","year":"1992","journal-title":"Funct Neurol"},{"key":"10.1016\/j.clinthera.2023.10.003_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7748\/ns.31.10.64.s47","article-title":"The British National Formulary","volume":"31","author":"Tallo","year":"2016","journal-title":"Nurs Stand"},{"key":"10.1016\/j.clinthera.2023.10.003_bib0006","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.alit.2016.07.004","article-title":"A case of eperisone hydrochloride-induced anaphylaxis: a true type I reaction?","volume":"66","author":"Miki","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.clinthera.2023.10.003_bib0007","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4103\/0253-7613.190765","article-title":"Eperisone hydrochloride-induced maculopapular rash","volume":"48","author":"Balaraddiyavar","year":"2016","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.clinthera.2023.10.003_bib0008","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1346-8138.2004.tb00595.x","article-title":"A case of eperisone hydrochloride-induced acute generalized exanthematous pustulosis","volume":"31","author":"Yamamoto","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.clinthera.2023.10.003_bib0009","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4168\/aair.2019.11.2.231","article-title":"Eperisone-induced anaphylaxis: pharmacovigilance data and results of allergy testing","volume":"11","author":"Park","year":"2019","journal-title":"Allergy Asthma Immun"},{"key":"10.1016\/j.clinthera.2023.10.003_bib0010","first-page":"709","article-title":"A case of eperisone hydrochloride (myonal)-induced drug eruption leading to erythema and angioedema","volume":"56","author":"Ueno","year":"2007","journal-title":"Allergy"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:59:48Z","timestamp":1758963588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823003958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0149291823003958"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.10.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle Strength Decline Caused by Eperisone Hydrochloride: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}